Polyrizon Ltd (PLRZ)
Polyrizon Ltd. (NASDAQ: PLRZ) is a biotechnology company focused on developing medical device hydrogels delivered as nasal sprays. Based in Israel, the company uses proprietary technology in products designed to create a barrier against allergen particulates and viruses, as well as to support nasal delivery of active pharmaceutical ingredients. Its development portfolio includes Capture and Contain, Trap and Target, PL-14 for nasal allergy blocking, PL-15 for COVID-19, and PL-16 for influenza-related protection. Incorporated in 2005, Polyrizon is headquartered in Ra'anana, Israel.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-PLRZ
|
$9.74
|
-11.4% Downside
|
Fair
|
Not available
|
Not available
|
Fair
|
0.0%
|
September 24, 2026
|
1.1x
|
23.127 M
|
4.836 M
|
0.0%
|
85.9%
|
53.6
|
136.0%
|
